“GLP-1 RECEPTOR AGONISTS AND COLORECTAL CANCER: BIOLOGICAL PLAUSIBILITY AND CURRENT EVIDENCE”, IJITSS, vol. 1, no. 1(49), Feb. 2026, doi: 10.31435/ijitss.1(49).2026.4822.